Procter & Gamble Health Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 500126 |
NSE Symbol : PGHL |
P/E(TTM) : 39.59 |
ISIN Demat : INE199A01012 |
Div & Yield% : 1.11 |
EPS(TTM) : 136.52 |
Book Value(₹) : 324.24 |
Market Cap(₹Cr) : 8,971.55 |
Face Value(₹) : 10.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 313.41 | 283.88 | 252.48 | 309.97 | 304.93 | 301.18 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 313.41 | 283.88 | 252.48 | 309.97 | 304.93 | 301.18 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 3.28 | 2.13 | 2.27 | 5.18 | 6.05 | 5.46 |
Total Income | 316.69 | 286.01 | 254.75 | 315.15 | 310.98 | 306.64 |
Total Expenditure | 199.37 | 255.82 | 185.04 | 208.32 | 216.27 | 255.84 |
PBIDT | 117.32 | 30.19 | 69.71 | 106.83 | 94.71 | 50.80 |
Interest | 0.15 | 0.20 | 0.15 | 0.19 | 0.18 | 0.17 |
PBDT | 117.17 | 29.99 | 69.56 | 106.64 | 94.53 | 50.63 |
Depreciation | 5.77 | 7.16 | 6.84 | 6.92 | 6.48 | 6.50 |
Tax | 27.95 | 12.79 | 16.30 | 29.56 | 22.29 | 15.11 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 1.12 | -6.74 | -0.14 | -1.91 | 0.19 | -0.80 |
Reported Profit After Tax | 82.33 | 16.78 | 46.56 | 72.07 | 65.57 | 29.82 |
Extra-ordinary Items | 0.00 | -8.88 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 82.33 | 25.66 | 46.56 | 72.07 | 65.57 | 29.82 |
EPS (Unit Curr.) | 49.60 | 9.50 | 28.00 | 43.40 | 39.50 | 17.96 |
EPS (Adj) (Unit Curr.) | 49.60 | 9.50 | 28.00 | 43.40 | 39.50 | 17.96 |
Calculated EPS (Unit Curr.) | 49.60 | 10.11 | 28.05 | 43.42 | 39.50 | 17.96 |
Calculated EPS (Adj) (Unit Curr.) | 49.60 | 10.11 | 28.05 | 43.42 | 39.50 | 17.96 |
Calculated EPS (Ann.) (Unit Curr.) | 198.39 | 40.43 | 112.19 | 173.66 | 158.00 | 71.86 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 198.39 | 40.43 | 112.19 | 173.66 | 158.00 | 71.86 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 2,000.00 | 0.00 | 0.00 |
Equity | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 37.43 | 10.63 | 27.61 | 34.46 | 31.06 | 16.87 |
PBDTM(%) | 37.39 | 10.56 | 27.55 | 34.40 | 31.00 | 16.81 |
PATM(%) | 26.27 | 5.91 | 18.44 | 23.25 | 21.50 | 9.90 |